Riskpilot← Back to searchSign inGet full accessCELLMOVER AS
ASActiveOrg 914987571Melkeveien 39B, 0779 OsloResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20157 employees
Revenue 2024
NOK 4,5M
+8% vs 2023
EBITDA margin
-0.6%
-114% vs 2023
Equity ratio
36.7%
Financial strength
Net profit 2024
NOK -117K
-249% vs 2023
| Revenue | NOK 4,5M | +8% |
| EBITDA | NOK -26K | -114% |
| Net profit | NOK -117K | -249% |
| Total assets | NOK 2M | +5% |
| Equity | NOK 750K | -14% |
| Employees | 7 | — |
Legal name
CELLMOVER AS
Org number
914987571
Legal form
Aksjeselskap
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
18. februar 2015
Share capital
NOK 85 000
Employees
7 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder og ett styremedlem hver for seg.
Company purpose
Forskning og utvikling metoder, legemidler og diagnostikk innen medisin og andre produkter/tjenester som naturlig hører sammen med dette.
Address
Melkeveien 39B, 0779 Oslo
Phone
+4795063929
Email
info@cellmover.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 549 | 309 | 232 | 1 651 | 3 189 | 3 756 | 4 153 | 4 497 |
| Staff expenses | −0 | −0 | −43 | −185 | −502 | −1 031 | −1 906 | −2 239 | −1 875 | −2 821 |
| EBITDA | −1 | −14 | 16 | −14 | −495 | 24 | −791 | −122 | 183 | −26 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −98 | −98 | −98 | −98 | −90 |
| EBIT | −1 | −14 | 16 | −14 | −495 | −74 | −888 | −220 | 85 | −115 |
| Net financials | 0 | 0 | 0 | −19 | −11 | −7 | −7 | −28 | −7 | −2 |
| Profit before tax | −1 | −14 | 16 | −32 | −507 | −81 | −896 | −248 | 79 | −117 |
| Tax | −3 | −3 | 4 | 2 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | 2 | −11 | 12 | −34 | −507 | −81 | −896 | −248 | 79 | −117 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 53 | 42 | 769 | 609 | 1 234 | 2 232 | 1 694 | 2 510 | 1 935 | 2 040 |
| Equity | 52 | 41 | 53 | 19 | 1 013 | 932 | 36 | 788 | 867 | 750 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1 | 1 | 715 | 590 | 222 | 1 300 | 1 658 | 1 722 | 1 069 | 1 291 |
| Total debt | 1 | 1 | 715 | 590 | 222 | 1 300 | 1 658 | 1 722 | 1 069 | 1 291 |
EBITDA margin
-0.6%
This company
15.8%
Market median
-104% vs market
20152024
Equity ratio
36.7%
This company
38.2%
Market median
+4% vs market
20152024
Return on equity
-15.6%
This company
18.4%
Market median
-185% vs market
20152024
Net profit margin
-2.6%
This company
8.1%
Market median
-132% vs market
20152024
Asset turnover
2.20×
This company
1.12×
Market median
+96% vs market
20152024
Debt / equity
1.72×
This company
0.62×
Market median
-177% vs market
20152024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-02 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
MI Chief Executive Officer | Chief Executive Officer | 2015 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2015 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Skilling Systemer As | Company | 41.2% | 41.2% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Skilling Systemer As
CELLMOVER AS Board members of CELLMOVER AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Marit Inngjerdingen | Chief Executive Officer | 0 companies |
| Eirik Næss-Ulseth | Board of Directors | 0 companies |